Browsing by Author "Stojnić, Jelena (13613250800)"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Correlation of oxidative stress markers and semen parameters with the outcome of in vitro fertilization(2020) ;Tulić, Lidija (6504063680) ;Ćurčić, Marijana (26321006800) ;Stojnić, Jelena (13613250800) ;Bulat, Zorica (24066576300)Protić, Isidora (57217538917)Introduction/Objective The aim was to assess the effect of oxidative stress parameters on sperm count, motility, and morphology of spermatozoa, and the influence of different semen parameters on the outcome of in vitro fertilization (IVF) procedure – the number of fertilized oocytes, fertilization, and pregnancy rate of female partners. Method In 52 male patients superoxide dismutase (SOD), malondialdehyde (MDA), and sulfhydryl (-SH) groups were determined in serum, before beginning the IVF cycle. Semen samples were collected after 2–3 days of sexual abstinence. Results Patients were divided into two groups, the normozoospermic, and those with pathological sperm findings. The second group was divided into oligozoospermic, asthenozoospermic, and teratozoospermic groups. SOD activity was lower, while MDA and-SH groups, while not significantly, was higher in groups with sperm parameter disorders. Fertilization rate was significantly lower in the group of asthenozoospermia and teratozoospermia (p = 0.034), as well as delivery rate (p = 0.020). The group with oligozoospermia had significantly lower delivery rate (p = 0.013). Conclusion Our study found higher fertilization and delivery rate in men with normozoospermia. However, no significant correlation between OS markers and semen parameters was found. © 2020, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Currently Available Treatment Modalities for Uterine Fibroids(2024) ;Micić, Jelena (7005054108) ;Macura, Maja (57219966636) ;Andjić, Mladen (57725550500) ;Ivanović, Katarina (57210170762) ;Dotlić, Jelena (6504769174) ;Micić, Dušan D. (37861889200) ;Arsenijević, Vladimir (58294885600) ;Stojnić, Jelena (13613250800) ;Bila, Jovan (57208312057) ;Babić, Sandra (57489797700) ;Šljivančanin, Una (59196806100) ;Stanišić, Danka Mostić (57219173539)Dokić, Milan (7004497269)Uterine fibroids (leiomyomas and myomas) are the most common benign gynecological condition in patients presenting with abnormal uterine bleeding, pelvic masses causing pressure or pain, infertility and obstetric complications. Almost a third of women with fibroids need treatment due to symptoms. Objectives: In this review we present all currently available treatment modalities for uterine fibroids. Methods: An extensive search for the available data regarding surgical, medical and other treatment options for uterine fibroids was conducted. Review: Nowadays, treatment for fibroids is intended to control symptoms while preserving future fertility. The choice of treatment depends on the patient’s age and fertility and the number, size and location of the fibroids. Current management strategies mainly involve surgical interventions (hysterectomy and myomectomy hysteroscopy, laparoscopy or laparotomy). Other surgical and non-surgical minimally invasive techniques include interventions performed under radiologic or ultrasound guidance (uterine artery embolization and occlusion, myolysis, magnetic resonance-guided focused ultrasound surgery, radiofrequency ablation of fibroids and endometrial ablation). Medical treatment options for fibroids are still restricted and available medications (progestogens, combined oral contraceptives andgonadotropin-releasing hormone agonists and antagonists) are generally used for short-term treatment of fibroid-induced bleeding. Recently, it was shown that SPRMs could be administered intermittently long-term with good results on bleeding and fibroid size reduction. Novel medical treatments are still under investigation but with promising results. Conclusions: Treatment of fibroids must be individualized based on the presence and severity of symptoms and the patient’s desire for definitive treatment or fertility preservation. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication DIFFERENT DOSES OF RECOMBINANT FSH AND DETERMINING PARAMETERS OF OXIDATIVE STRESS; [RAZLI^ITE DOZE REKOMBINANTNOG FSH I ODRE\IVANJE PARAMETARA OKSIDATIVNOG STRESA](2024) ;Tulić, Lidija (6504063680) ;Tulić, Ivan (6602743219) ;Stojnić, Jelena (13613250800) ;Bila, Jovan (57208312057) ;Vuković, Željka (59033553000)Kotlica, Boba (57719578900)Background: This study aimed to examine if there is a connection between recombinant FSH dose and OS parameters in serum and the impact on IVF outcome. Methods: This study consisted of 101 participants that went through IVF procedures. Parameter that were tested are SOD, SH groups and MDA. Serum samples were drawn before stimulation and on the last day of ovarian stimulation. Results: Two groups were formed according to the dose of gonadotropins (rFSH). In both groups there were no significant differences in live–birth rate and miscarriage. In both groups mean serum MDA and SH-groups were significantly higher after ovarian stimulation, but mean serum SOD was significantly lower when compared to values before stimulation. There were less patients without OS before stimulation. Conclusions: Our results suggest that there is a difference in serum concentration in groups SOD, SH groups and MDA at the beginning and at the end ovarian stimulation. On the other hand, dose of rFSH is not related with change of parameters for oxidative stress, quality of oocytes, embryos, fertilization, pregnancies, and miscarriage rate. Patients without oxidative stress before the IVF procedure needed lower doses of gonadotropins during stimulation. © 2024 Society of Medical Biochemists of Serbia. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication DIFFERENT DOSES OF RECOMBINANT FSH AND DETERMINING PARAMETERS OF OXIDATIVE STRESS; [RAZLI^ITE DOZE REKOMBINANTNOG FSH I ODRE\IVANJE PARAMETARA OKSIDATIVNOG STRESA](2024) ;Tulić, Lidija (6504063680) ;Tulić, Ivan (6602743219) ;Stojnić, Jelena (13613250800) ;Bila, Jovan (57208312057) ;Vuković, Željka (59033553000)Kotlica, Boba (57719578900)Background: This study aimed to examine if there is a connection between recombinant FSH dose and OS parameters in serum and the impact on IVF outcome. Methods: This study consisted of 101 participants that went through IVF procedures. Parameter that were tested are SOD, SH groups and MDA. Serum samples were drawn before stimulation and on the last day of ovarian stimulation. Results: Two groups were formed according to the dose of gonadotropins (rFSH). In both groups there were no significant differences in live–birth rate and miscarriage. In both groups mean serum MDA and SH-groups were significantly higher after ovarian stimulation, but mean serum SOD was significantly lower when compared to values before stimulation. There were less patients without OS before stimulation. Conclusions: Our results suggest that there is a difference in serum concentration in groups SOD, SH groups and MDA at the beginning and at the end ovarian stimulation. On the other hand, dose of rFSH is not related with change of parameters for oxidative stress, quality of oocytes, embryos, fertilization, pregnancies, and miscarriage rate. Patients without oxidative stress before the IVF procedure needed lower doses of gonadotropins during stimulation. © 2024 Society of Medical Biochemists of Serbia. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Oxidative Stress Markers in GnRH AgonistaAnd Antagonist Protocols in IVF(2017) ;Tulić, Lidija (6504063680) ;Vidaković, Sneana (9434348100) ;Tulić, Ivan (6602743219) ;Curčić, Marijana (26321006800) ;Stojnić, Jelena (13613250800)Jeremić, Katarina (6701486495)Background: Our aim was to study the effect of GnRH agonist and antagonist protocols of ovarian stimulation on oxidative stress parameters in serum and the influence of oxidative stress parameters change on the outcome of IVF cycles. Methods: This prospective study included 82 patients who un der went IVF procedures. We determined SOD, MDA and SH groups in serum. Serum samples were obtained between the second and fourth day of the cycle and on the day of HCG administration during ovarian stimulation. Results: Patients were divided into two groups depending on the protocol of stimulation. The mean total and mature oocytes number and number of fertilized oocytes were higher in GnRH agonist group. There was no significant difference in biochemical pregnancy, miscarriage and live -birth rate in both groups. Mean serum SOD was significantly lower, while mean serum MDA and SH groups were significantly higher after ovarian stimulation. Delivery rate was higher in patients without OS while miscarriage rate was higher in patients with OS. Conclusions: Our study confirmed that there is a difference in the concentration of oxidative stress parameters before and after ovarian stimulation. IVF outcome is better in patients without OS after ovarian stimulation. However, the protocol of ovarian stimulation is neither associated with a change in oxidative stress parameters nor with the outcome of ART procedures. © 2017 by Lidija Tulić. - Some of the metrics are blocked by yourconsent settings
Publication Oxidative Stress Markers in GnRH AgonistaAnd Antagonist Protocols in IVF(2017) ;Tulić, Lidija (6504063680) ;Vidaković, Sneana (9434348100) ;Tulić, Ivan (6602743219) ;Curčić, Marijana (26321006800) ;Stojnić, Jelena (13613250800)Jeremić, Katarina (6701486495)Background: Our aim was to study the effect of GnRH agonist and antagonist protocols of ovarian stimulation on oxidative stress parameters in serum and the influence of oxidative stress parameters change on the outcome of IVF cycles. Methods: This prospective study included 82 patients who un der went IVF procedures. We determined SOD, MDA and SH groups in serum. Serum samples were obtained between the second and fourth day of the cycle and on the day of HCG administration during ovarian stimulation. Results: Patients were divided into two groups depending on the protocol of stimulation. The mean total and mature oocytes number and number of fertilized oocytes were higher in GnRH agonist group. There was no significant difference in biochemical pregnancy, miscarriage and live -birth rate in both groups. Mean serum SOD was significantly lower, while mean serum MDA and SH groups were significantly higher after ovarian stimulation. Delivery rate was higher in patients without OS while miscarriage rate was higher in patients with OS. Conclusions: Our study confirmed that there is a difference in the concentration of oxidative stress parameters before and after ovarian stimulation. IVF outcome is better in patients without OS after ovarian stimulation. However, the protocol of ovarian stimulation is neither associated with a change in oxidative stress parameters nor with the outcome of ART procedures. © 2017 by Lidija Tulić.
